Blood glucose monitoring devices are used by diabetics to measure and manage their blood glucose levels. These technologies allow patients to check their blood glucose levels quickly and non-invasively. The devices do a quantitative test to determine blood glucose levels. People can control their condition by monitoring blood glucose levels and seeking medical attention when necessary.
According to SPER market research, ‘Asia Pacific Blood Glucose Monitoring Market Size – By Self-monitoring Blood Glucose Devices, By Continuous Glucose Monitoring Devices, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ state that the APAC Blood Glucose Monitoring Market is predicted to reach USD 7.53 billion by 2033 with a CAGR of 7.98%.
Drivers:
The prevalence of Type 1 and Type 2 diabetes among recently diagnosed cases is rising, mostly as a result of poor diet, inactivity, and obesity. The number of people with diabetes and the increase in healthcare spending are signs that the usage of diabetic care products is rising in developed countries. Furthermore, drivers propelling market expansion include the rising incidence of diabetes and the rising adoption of insulin delivery devices. Prominent producers are prioritizing technological innovations and the creation of unique items as means of capturing a substantial share of the market. Over the course of the research, these elements should lead to a growth in the market that is being examined.
Challenges:
Numerous challenges stand in the way of the blood glucose monitoring market’s expansion and growth in the Asia-Pacific region. One major barrier is the disparity in healthcare facilities and accessibility caused by the area’s various economic settings. Modern blood glucose monitoring equipment may be difficult for less developed nations to adopt, which would impede its market penetration. Moreover, cultural backgrounds and variations in healthcare laws hinder the smooth integration and standardization of blood glucose monitoring systems. The availability of fake goods is a serious issue that has to be addressed since it has the ability to skew blood glucose tests and have a detrimental effect on patient outcomes.
Request For Free Sample Report @ https://www.sperresearch.com/report-store/asia-pacific-blood-glucose-monitoring-market.aspx?sample=1
Impact of COVID-19 on APAC Blood Glucose Monitoring Market
The COVID-19 epidemic contributes to the growth of the Asia-Pacific Diabetes Care Devices Market. People with diabetes who test positive for COVID-19 may experience unusual fluctuations in blood sugar, elevated blood sugar, and other diabetes-related problems. The severity and mortality of COVID-19 were significantly higher in people with diabetes, especially in those with poor glycemic control and type 1 (T1DM) or type 2 (T2DM) diabetes mellitus. Furthermore, the emergence of diabetes (T1DM and T2DM) and hyperglycemia has been associated with inferior outcomes and has been seen more frequently in the COVID-19 scenario.
Asia Pacific Blood Glucose Monitoring Market Key Players:
Furthermore, China is currently experiencing the world’s largest diabetes epidemic, with approximately 10% of the population pre-diabetic and 10% suffering from metabolic illness. Due to a sizable patient base and widespread adoption of cutting-edge technology, China commanded the greatest market share in the Asia-Pacific blood glucose monitoring sector in 2018. Additionally some of the market players are: Abbott Diabetes Care, Acon, Agamatrix Inc., Arkray, Ascensia Diabetes Care, Bionime Corporation, Dexcom.
Asia Pacific Blood Glucose Monitoring Market Segmentation:
The SPER Market Research report seeks to give market dynamics, demand, and supply forecast for the years up to 2033. This report contains statistics on product type segment growth estimates and forecasts.
By Self-monitoring Blood Glucose Devices: Based on the Self-monitoring Blood Glucose Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Glucometer Devices, Test Strips, Lancets.
By Continuous Glucose Monitoring Devices: Based on the Continuous Glucose Monitoring Devices, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Sensors, Durables.
By End User: Based on the End User, Asia-Pacific Blood Glucose Monitoring Market is segmented as; Hospital/Clinics, Home/Personal.
By Region: This research also includes data for China, Japan, Australia, India, Rest of Asia Pacific.
This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.
For More Information, refer to below link:-
APAC Blood Glucose Monitoring Market Future Outlook
Related Reports:
Follow Us –
LinkedIn | Instagram | Facebook | Twitter
Contact Us:
Sara Lopes, Business Consultant – U.S.A.
SPER Market Research
+1-347-460-2899
